Citadel Advisors LLC Takes Position in Alzamend Neuro, Inc. (NASDAQ:ALZN)
Citadel Advisors LLC purchased a new stake in Alzamend Neuro, Inc. (NASDAQ:ALZN – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 30,638 shares of the company’s stock, valued at approximately $36,000. Separately, Geode Capital Management LLC purchased a new stake in Alzamend Neuro during the fourth quarter valued at approximately $39,000. Hedge […]
Citadel Advisors LLC purchased a new stake in Alzamend Neuro, Inc. (NASDAQ:ALZN – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 30,638 shares of the company’s stock, valued at approximately $36,000. Separately, Geode Capital Management LLC purchased a new stake in Alzamend Neuro during the fourth quarter valued at approximately $39,000. Hedge […]
